John Alexander
Latest contributions
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction
28 Aug 2022
Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.
Author
Author
Aortic stenosis in the younger patient: procedural complications and lifetime management
21 Nov 2021 – From PCR London Valves 2021
Biological, surgical valves and TAVIs are being implanted in younger and younger patients. Since these procedures must be planned in the best possible way to minimize future complications, and because the lifetime management of these patients must be thought of, watch this session to get very useful...
